Antidiabetic antihyperlipidemic and hepato-protective effect of Gluconorm-5: A polyherbal formulation in steptozotocin induced hyperglycemic rats

Background: The antidiabetic, antihyperlipidemic, and hepato-protective effect of Gluconorm-5, was studied in steptozotocin (STZ) induced hyperglycemic rats. Materials and Methods: The hypoglycemic effect of single dose of Gluconorm-5 (150, 300 and 600 mg/kg body weight) made up of five plants name...

Full description

Bibliographic Details
Main Authors: Kalavathy Gengiah, Rajeswary Hari, J Anbu
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2014-01-01
Series:Ancient Science of Life
Subjects:
Online Access:http://www.ancientscienceoflife.org/article.asp?issn=0257-7941;year=2014;volume=34;issue=1;spage=23;epage=32;aulast=Gengiah
_version_ 1819073849102172160
author Kalavathy Gengiah
Rajeswary Hari
J Anbu
author_facet Kalavathy Gengiah
Rajeswary Hari
J Anbu
author_sort Kalavathy Gengiah
collection DOAJ
description Background: The antidiabetic, antihyperlipidemic, and hepato-protective effect of Gluconorm-5, was studied in steptozotocin (STZ) induced hyperglycemic rats. Materials and Methods: The hypoglycemic effect of single dose of Gluconorm-5 (150, 300 and 600 mg/kg body weight) made up of five plants namely Camellia sinensis, Punica granatum, Macrotyloma uniflorum, Foeniculum vulgare and Trigonella foenum-graecum was studied in normal, glucose loaded normal and diabetes-induced rats. The extent of antihyperlipidemic and liver-protective effect was studied by estimating the lipid profile, and the liver marker enzymes. Histopathological studies of the pancreatic tissue were also carried out with glibenclamide as standard antihyperglycemic agent. Results: Fifteen days of oral feeding of the Gluconorm-5 (300 and 600 mg/kg) to diabetic rats resulted in a significant (P < 0.01) reduction of blood glucose, lipid profile, liver weight and marker enzymes as compared to those rats in whom STZ induced toxicity was untreated. The diabetic rats treated with the drug showed expanded islets as compared to the untreated diabetic rats, which showed the shrunken islets. The animals that received 300 mg/kg of Gluconorm-5 showed pronounced antidiabetic, antihyperlipidemic and hepato-protective effect in the present study, which was comparable with glibenclamide, a standard drug. Conclusion: Gluconorm-5 exerts potent antidiabetic antihyperlipidemic and hepato-protective effect, which can be used as adjuvant in the treatment of diabetes mellitus.
first_indexed 2024-12-21T18:00:09Z
format Article
id doaj.art-221a8664f8954ceab4871c8509a4cb73
institution Directory Open Access Journal
issn 0257-7941
language English
last_indexed 2024-12-21T18:00:09Z
publishDate 2014-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Ancient Science of Life
spelling doaj.art-221a8664f8954ceab4871c8509a4cb732022-12-21T18:55:05ZengWolters Kluwer Medknow PublicationsAncient Science of Life0257-79412014-01-01341233210.4103/0257-7941.150773Antidiabetic antihyperlipidemic and hepato-protective effect of Gluconorm-5: A polyherbal formulation in steptozotocin induced hyperglycemic ratsKalavathy GengiahRajeswary HariJ AnbuBackground: The antidiabetic, antihyperlipidemic, and hepato-protective effect of Gluconorm-5, was studied in steptozotocin (STZ) induced hyperglycemic rats. Materials and Methods: The hypoglycemic effect of single dose of Gluconorm-5 (150, 300 and 600 mg/kg body weight) made up of five plants namely Camellia sinensis, Punica granatum, Macrotyloma uniflorum, Foeniculum vulgare and Trigonella foenum-graecum was studied in normal, glucose loaded normal and diabetes-induced rats. The extent of antihyperlipidemic and liver-protective effect was studied by estimating the lipid profile, and the liver marker enzymes. Histopathological studies of the pancreatic tissue were also carried out with glibenclamide as standard antihyperglycemic agent. Results: Fifteen days of oral feeding of the Gluconorm-5 (300 and 600 mg/kg) to diabetic rats resulted in a significant (P < 0.01) reduction of blood glucose, lipid profile, liver weight and marker enzymes as compared to those rats in whom STZ induced toxicity was untreated. The diabetic rats treated with the drug showed expanded islets as compared to the untreated diabetic rats, which showed the shrunken islets. The animals that received 300 mg/kg of Gluconorm-5 showed pronounced antidiabetic, antihyperlipidemic and hepato-protective effect in the present study, which was comparable with glibenclamide, a standard drug. Conclusion: Gluconorm-5 exerts potent antidiabetic antihyperlipidemic and hepato-protective effect, which can be used as adjuvant in the treatment of diabetes mellitus.http://www.ancientscienceoflife.org/article.asp?issn=0257-7941;year=2014;volume=34;issue=1;spage=23;epage=32;aulast=GengiahAntidiabeticantihyperlipidemicGluconorm-5hepato-protective
spellingShingle Kalavathy Gengiah
Rajeswary Hari
J Anbu
Antidiabetic antihyperlipidemic and hepato-protective effect of Gluconorm-5: A polyherbal formulation in steptozotocin induced hyperglycemic rats
Ancient Science of Life
Antidiabetic
antihyperlipidemic
Gluconorm-5
hepato-protective
title Antidiabetic antihyperlipidemic and hepato-protective effect of Gluconorm-5: A polyherbal formulation in steptozotocin induced hyperglycemic rats
title_full Antidiabetic antihyperlipidemic and hepato-protective effect of Gluconorm-5: A polyherbal formulation in steptozotocin induced hyperglycemic rats
title_fullStr Antidiabetic antihyperlipidemic and hepato-protective effect of Gluconorm-5: A polyherbal formulation in steptozotocin induced hyperglycemic rats
title_full_unstemmed Antidiabetic antihyperlipidemic and hepato-protective effect of Gluconorm-5: A polyherbal formulation in steptozotocin induced hyperglycemic rats
title_short Antidiabetic antihyperlipidemic and hepato-protective effect of Gluconorm-5: A polyherbal formulation in steptozotocin induced hyperglycemic rats
title_sort antidiabetic antihyperlipidemic and hepato protective effect of gluconorm 5 a polyherbal formulation in steptozotocin induced hyperglycemic rats
topic Antidiabetic
antihyperlipidemic
Gluconorm-5
hepato-protective
url http://www.ancientscienceoflife.org/article.asp?issn=0257-7941;year=2014;volume=34;issue=1;spage=23;epage=32;aulast=Gengiah
work_keys_str_mv AT kalavathygengiah antidiabeticantihyperlipidemicandhepatoprotectiveeffectofgluconorm5apolyherbalformulationinsteptozotocininducedhyperglycemicrats
AT rajeswaryhari antidiabeticantihyperlipidemicandhepatoprotectiveeffectofgluconorm5apolyherbalformulationinsteptozotocininducedhyperglycemicrats
AT janbu antidiabeticantihyperlipidemicandhepatoprotectiveeffectofgluconorm5apolyherbalformulationinsteptozotocininducedhyperglycemicrats